# Phase I Pediatric FMP2.1/AS02A Trial in Mali

> **NCT00358332** · PHASE1 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 100 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **BIOLOGICAL:** FMP2.1/AS02A
- **BIOLOGICAL:** Rabies vaccine (RabAvert)

## Key facts

- **NCT ID:** NCT00358332
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-10-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358332, "Phase I Pediatric FMP2.1/AS02A Trial in Mali". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00358332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*